Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending StockZacks Investment Research • 10/15/26
Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to makeCNBC • 10/14/26
Federal and state regulators asked a judge to hold “pharma bro” Martin Shkreli in contempt, alleging he traded drug stocks despite a lifetime ban from the pharmaceutical industryWSJ • 10/13/26
FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma banBusiness Insider • 10/13/26
‘Pharma Bro' Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocksMarket Watch • 10/13/26
Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of DirectorsBusiness Wire • 10/13/26
Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026Business Wire • 10/13/26
Jefferies cuts Merck's remigromig sales forecast after eye-disease trial raises concernsProactive Investors • 10/12/26
Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer VaccinesZacks Investment Research • 10/12/26
Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?Zacks Investment Research • 10/12/26
Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026Business Wire • 10/10/26
Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks24/7 Wall Street • 10/09/26
HP, Merck, and Seagate Just Paid Their Shareholders. Here's What Landed in Their Accounts.24/7 Wall Street • 10/08/26
Halozyme wins court order to block Merck's injected Keytruda in select European marketsReuters • 10/07/26
Merck (MRK) Beats Stock Market Upswing: What Investors Need to KnowZacks Investment Research • 10/06/26